• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-18 对全身型幼年特发性关节炎的诊断和病程预测的临床意义。

Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis.

机构信息

Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa.

Department of Pediatric Rheumatology, Hyogo Prefectural Kobe Children's Hospital, Kobe.

出版信息

Rheumatology (Oxford). 2021 May 14;60(5):2421-2426. doi: 10.1093/rheumatology/keaa634.

DOI:10.1093/rheumatology/keaa634
PMID:33200207
Abstract

OBJECTIVE

To investigate the clinical significance of serum IL-18 levels for the diagnosis of systemic JIA (s-JIA) and to predict the disease course of s-JIA.

METHODS

Overall, 116 patients with s-JIA, 151 with other diseases and 20 healthy controls were analysed. Serum IL-18 levels were measured longitudinally in 41 patients with s-JIA from active phase through remission phase. Serum IL-18 levels were quantified via enzyme-linked immunosorbent assay and the results were compared with clinical features and the disease course of s-JIA.

RESULTS

The serum IL-18 level cut-off value for differentiation of s-JIA from other diseases was 4800 pg/ml. In patients with a monocyclic course, serum IL-18 levels steadily decreased during the inactive phase and low levels were sustained during remission. In contrast, in patients with a chronic course, elevated serum IL-18 levels were sustained even during the inactive phase. In patients with a polycyclic course, serum IL-18 levels were elevated during disease flares and normalized during the inactive phase. The serum IL-18 level cut-off value for diagnosis of remission in s-JIA was 595 pg/ml.

CONCLUSION

Serum IL-18 levels of >4800 pg/ml may be useful for differentiating between s-JIA and other diseases. Monitoring of serum IL-18 levels might be useful for predicting the disease course and assessing remission in s-JIA.

摘要

目的

探讨血清白细胞介素-18(IL-18)水平对全身幼年特发性关节炎(s-JIA)的诊断意义,并预测 s-JIA 的病程。

方法

分析了 116 例 s-JIA 患者、151 例其他疾病患者和 20 名健康对照者的资料。对 41 例 s-JIA 患者从活动期到缓解期进行了血清 IL-18 水平的纵向检测。采用酶联免疫吸附试验定量检测血清 IL-18 水平,并与 s-JIA 的临床特征和病程进行比较。

结果

s-JIA 与其他疾病鉴别时,血清 IL-18 水平的截断值为 4800 pg/ml。在单周期病程患者中,血清 IL-18 水平在缓解期持续下降,在缓解期持续维持低水平。相反,在慢性病程患者中,即使在缓解期,血清 IL-18 水平也持续升高。在多周期病程患者中,疾病活动期血清 IL-18 水平升高,缓解期正常。s-JIA 缓解期诊断的血清 IL-18 水平截断值为 595 pg/ml。

结论

血清 IL-18 水平>4800 pg/ml 可能有助于区分 s-JIA 和其他疾病。监测血清 IL-18 水平可能有助于预测 s-JIA 的病程和评估缓解。

相似文献

1
Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis.白细胞介素-18 对全身型幼年特发性关节炎的诊断和病程预测的临床意义。
Rheumatology (Oxford). 2021 May 14;60(5):2421-2426. doi: 10.1093/rheumatology/keaa634.
2
Serum Leucine-Rich 2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis.血清富含亮氨酸的 2 糖蛋白作为系统性幼年特发性关节炎患者疾病活动监测的生物标志物。
J Immunol Res. 2019 Feb 4;2019:3140204. doi: 10.1155/2019/3140204. eCollection 2019.
3
Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.可溶性 CD163,一种独特的生物标志物,可用于评估疾病活动度,在系统性幼年特发性关节炎中表现出巨噬细胞激活。
Cytokine. 2018 Oct;110:459-465. doi: 10.1016/j.cyto.2018.05.017. Epub 2018 May 24.
4
Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease.血清白细胞介素-18作为鉴别全身型幼年特发性关节炎与不完全川崎病的潜在特异性标志物。
Rheumatol Int. 2015 Jan;35(1):81-4. doi: 10.1007/s00296-014-3059-2. Epub 2014 Jun 12.
5
Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.比较托珠单抗治疗系统性幼年特发性关节炎并发巨噬细胞活化综合征的血清生物标志物。
Pediatr Res. 2020 Dec;88(6):934-939. doi: 10.1038/s41390-020-0843-4. Epub 2020 Mar 17.
6
Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.可溶性 ST2 作为全身型幼年特发性关节炎疾病活动的标志物。
Cytokine. 2013 May;62(2):272-7. doi: 10.1016/j.cyto.2013.03.007. Epub 2013 Apr 3.
7
Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis.白细胞介素-18作为全身型幼年特发性关节炎的介质
Clin Rheumatol. 2007 Aug;26(8):1332-4. doi: 10.1007/s10067-006-0474-0. Epub 2006 Nov 25.
8
Serum interleukin-18 levels can improve the diagnostic performance of the PRINTO and ILAR criteria for systemic juvenile idiopathic arthritis.血清白细胞介素-18 水平可以提高 PRINTO 和 ILAR 标准对全身型幼年特发性关节炎的诊断性能。
Cytokine. 2024 Oct;182:156719. doi: 10.1016/j.cyto.2024.156719. Epub 2024 Jul 30.
9
Compensated inflammation in systemic juvenile idiopathic arthritis: role of alternatively activated macrophages.全身型幼年特发性关节炎的代偿性炎症:交替活化巨噬细胞的作用。
Cytokine. 2012 Oct;60(1):226-32. doi: 10.1016/j.cyto.2012.05.003. Epub 2012 Jun 8.
10
Serum interleukin-18 level as a possible early diagnostic marker of systemic juvenile idiopathic arthritis.血清白细胞介素-18 水平作为全身型幼年特发性关节炎的一种潜在早期诊断标志物。
Int J Rheum Dis. 2023 Mar;26(3):551-553. doi: 10.1111/1756-185X.14534. Epub 2022 Dec 16.

引用本文的文献

1
Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohort.炎症生物标志物预测青少年特发性关节炎的长期缓解和活动性疾病:北欧 JIA 队列的一项基于人群的研究。
RMD Open. 2024 Sep 5;10(3):e004317. doi: 10.1136/rmdopen-2024-004317.
2
Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.细胞因子风暴综合征与全身型幼年特发性关节炎相关。
Adv Exp Med Biol. 2024;1448:323-353. doi: 10.1007/978-3-031-59815-9_23.
3
Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease Continuum.
将系统性幼年特发性关节炎和成人斯蒂尔病作为斯蒂尔病连续谱的一部分进行诊断和治疗。
Mediterr J Rheumatol. 2024 Mar 30;35(Suppl 1):45-57. doi: 10.31138/mjr.290323.dat. eCollection 2024 Mar.
4
Heterogeneity of macrophage activation syndrome and treatment progression.巨噬细胞活化综合征的异质性和治疗进展。
Front Immunol. 2024 Apr 26;15:1389710. doi: 10.3389/fimmu.2024.1389710. eCollection 2024.
5
IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome.白细胞介素 18 在自身炎症性疾病中的作用:以成人Still 病和巨噬细胞活化综合征为例。
Int J Mol Sci. 2023 Jul 5;24(13):11125. doi: 10.3390/ijms241311125.
6
When to stop medication in juvenile idiopathic arthritis.何时停止青少年特发性关节炎的药物治疗。
Curr Opin Rheumatol. 2023 Sep 1;35(5):265-272. doi: 10.1097/BOR.0000000000000948. Epub 2023 May 3.
7
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.全身性幼年特发性关节炎和巨噬细胞活化综合征的小鼠模型。
Arthritis Res Ther. 2023 Mar 25;25(1):48. doi: 10.1186/s13075-023-03032-8.
8
Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era.全身性幼年特发性关节炎、巨噬细胞活化综合征中的生物标志物及其在新冠时代的重要性。
Int J Mol Sci. 2022 Oct 22;23(21):12757. doi: 10.3390/ijms232112757.
9
Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases.改善获得性系统性自身炎症性疾病的诊断与临床管理。
J Inflamm Res. 2022 Oct 10;15:5739-5755. doi: 10.2147/JIR.S343261. eCollection 2022.
10
Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases.白细胞介素-18 在自身炎症性疾病中的致病作用和诊断效用。
Front Immunol. 2022 Sep 22;13:951535. doi: 10.3389/fimmu.2022.951535. eCollection 2022.